Osaka, Japan

Takashi Konemura

This inventor holds 3 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Ono Pharmaceutical Co., Ltd.. Active years: 2015-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takashi Konemura. Retrieved from https://idiyas.com/inventor/takashi-konemura

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 3 

% Patents Active = 66.7

 

Average Co-Inventor Count = 4.1

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Mishima-gun, JP (2015)
  • Osaka, JP (2022)

Company Filing History:


Years Active: 2015-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Takashi Konemura: Innovator in Neuropathy Therapeutics

Introduction

Takashi Konemura is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of neuropathy therapeutics. With a total of 3 patents, his work focuses on developing compounds that can aid in nerve protection and repair.

Latest Patents

One of his latest patents involves a benzene derivative, which is represented by a general formula. This compound exhibits potent nerve-protecting and/or -repairing activity. It has potential applications as a therapeutic agent for various neuropathies, including chronic inflammatory demyelinating polyneuropathy, Guillain-Barre syndrome, and diabetic peripheral neuropathy.

Career Highlights

Takashi Konemura is associated with Ono Pharmaceutical Co., Ltd., where he continues to innovate in the field of pharmaceuticals. His research has been pivotal in advancing therapeutic options for patients suffering from nerve-related conditions.

Collaborations

He has collaborated with notable colleagues, including Shoji Nojima and Kenji Sasaki, to further enhance the impact of his research and inventions.

Conclusion

Takashi Konemura's contributions to neuropathy therapeutics highlight his dedication to improving patient outcomes through innovative solutions. His work continues to inspire advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…